Slash Pine Allergy Shots: The Southeast Plantation Myth-Buster
Slash pine (Pinus elliottii) carpets Florida, Georgia, Alabama, and South Carolina in yellow pollen each March–April, yet Bucholtz 1985 found only 3.2% of pollen-sensitive patients test positive to Pinus. The real Southeast spring allergens — live oak (Quercus virginiana), bayberry (Myrica/Morella), and sweet gum — overlap slash pine season and are far more clinically relevant. Testing before pursuing SCIT is essential; no RCT exists for slash pine.
Slash Pine Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to slash pine — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of slash pine allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of slash pine immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of slash pine extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for slash pine allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing slash pine extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription slash pine immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat slash pine allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Slash Pine?
The biology, taxonomy, and clinical fingerprint of Slash Pine — the foundation of how SCIT targets it.
Slash pine (Pinus elliottii) plantations across 13 million acres of the coastal Southeast deposit visible yellow pollen in March–April — but clinical allergy rates remain low, with the concurrent live oak and bayberry seasons driving most spring rhinitis.
- Scientific name
- Pinus elliottii
- Family
- PinaceaePine family
- Type
- Conifer plantation tree pollen
- Native to
- Coastal plain of southeastern US — Florida, Georgia, Alabama, Mississippi, South Carolina
- Allergen proteins
- No IUIS-named allergen registered for Pinus elliottii; IgE-binding bands at 42 kDa and 6–8 kDa shared across Pinus genus (Gastaminza 2009)
- Particle size
- 60–80 μm (saccate, two air sacs)
- Avoidance difficulty
- Very difficult
How Slash Pine Allergy Presents
Symptoms by body system — useful for distinguishing Slash Pine sensitivity from overlapping allergies and infections.
Respiratory
- Nasal congestion and sneezing during March–April coastal-plain pollen events
- Runny nose coinciding with visible yellow pine dust on cars and outdoor surfaces
- Mild asthma exacerbation in confirmed Pinus-sensitized individuals
- Prolonged symptom burden often attributable to overlapping live oak and bayberry seasons
Ocular
- Itchy, watery eyes during peak March–April pollen events
- Conjunctival redness from sustained outdoor exposure in plantation areas
- Mild eyelid swelling in sensitized individuals
Dermal
- Contact urticaria from direct pollen contact in high-density plantation settings (uncommon)
- Pine resin contact dermatitis — distinct from IgE-mediated pollen allergy
- Mild skin itching from outdoor exposure during peak pollen deposition
Systemic
- Fatigue from disrupted sleep during the extended Southeast pollen season
- Reduced outdoor activity tolerance in heavy-plantation coastal-plain communities
- Symptom misattribution — live oak and bayberry overlap slash pine timing and are more clinically significant
Every March in Jacksonville and Tallahassee the cars turn yellow and patients call asking for pine allergy shots. We test, and nine times out of ten the real culprit is live oak or bayberry. The yellow on the car is mostly cosmetic — the inflammation comes from something else blooming at the same time.
When & Where Slash Pine Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: March–April in the coastal plain; NAB Tampa and Jacksonville stations log counts >1,000 grains/m³· Approximately 8–10 weeks in the Southeast; longer warm-season duration than northern pines
US Exposure Map
5 high-intensity statesWhat Slash Pine Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Slash pine shares near-complete IgE cross-reactivity with all Pinus species, but does not cross-react with Cupressaceae — an important distinction for Southeast patients who may confuse pine season with concurrent mold or other tree exposures.
Near-complete intra-Pinus cross-reactivity; loblolly and slash overlap geographically in the Carolinas
Is SCIT Right for Your Slash Pine Allergy?
Answer five questions to assess whether slash pine allergy shots are the right immunotherapy target for your Southeast spring symptoms.
How severe are your spring pollen symptoms during March–April in the Southeast?
The Slash Pine SCIT Protocol
Slash pine SCIT follows the standard inhalant build-up schedule with a non-standardized extract; your allergist may include slash pine in a multi-species southeastern pine mix rather than as a single-species vial.
Weekly injections escalate the slash pine extract concentration over 16–24 weeks. Your allergist calibrates starting dose based on skin-test reactivity to the non-standardized extract. A 30-minute observation period after every injection is mandatory.
At the target maintenance dose, injections shift to monthly clinic visits. Lot-to-lot variability in non-standardized pine extracts may prompt dose adjustment when new vials arrive. Symptom diary review at 12 months assesses clinical response.
After completing a full course, some patients achieve durable tolerance and discontinue; others continue. No slash pine-specific data inform this decision — it is based on clinical response.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Slash Pine SCIT
No randomized controlled trial has been published for slash pine SCIT — the evidence rests on observational data and extrapolation from the inhalant SCIT class, alongside the foundational pollen-immunology studies.
- Pinus sensitization in unselected pollen-allergic patients3%Bucholtz GA et al., J Allergy Clin Immunol, 1985, N=155
- IgE positivity in selected pine-allergic cohort69%Gastaminza G et al., Clin Exp Allergy, 2009, N=selected cohort
- Inhalant SCIT symptom reduction (class-level)60%Cox L et al., JACI, 2011 — AAAAI Practice Parameter meta-summary
No RCT has specifically studied slash pine SCIT. Bayberry (Morella cerifera) allergy was confirmed as a true Southeast aeroallergen by Jacinto et al. (JACI, 1992) with positive bronchial challenges — whereas pine lacks equivalent clinical proof of concept. Testing before SCIT initiation prevents years of treatment aimed at the wrong allergen.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Slash Pine SCIT Side Effects
Slash pine SCIT carries the standard inhalant SCIT side-effect profile, with the same lot-to-lot variability caution as all non-standardized pine extracts.
Local reactions
3 documentedSystemic reactions
3 documentedThe mandatory 30-minute post-injection observation period is a non-negotiable AAAAI safety standard. No deaths from properly supervised SCIT have been reported in the US in the past decade with adherence to these protocols.
SCIT vs Alternatives for Slash Pine
For Southeast patients with confirmed slash pine sensitization, allergy shots (SCIT) — now available as an at-home weekly injection with Curex — sublingual drops, avoidance, and daily medications are the main options, each with different tradeoffs for coastal-plain populations with long pollen seasons.
| Criterion | SCITBest | SLIT | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | Moderate (no RCT; inhalant class extrapolation) | Emerging; no slash pine-specific trial | Limited — plantation pollen is unavoidable | Symptomatic relief only |
| 5-yr cost | $3,500–$15,000 | Varies by provider; sold as a general sublingual modality, not Curex's product | Low | $500–$2,000/year |
| Duration | 3–5 years | 3–5 years | Ongoing | Indefinite |
| Convenience | At-home weekly self-injection with Curex during build-up; first dose and dose changes supervised live over Zoom | Daily drops at home | HEPA filters, windows closed March–April | Daily pills/sprays |
| Safety | USP <797> sterile-compounded serum, Zoom-supervised dosing, prescribed epinephrine on hand, 30-min self-observation | Lower systemic reaction risk vs SCIT | Safe | Safe; antihistamine sedation risk |
| Lasting effect | Possible lasting tolerance | Possible lasting benefit | No immune modification | No lasting effect |
SCITBest
SLIT
Avoidance
Medications
For Southeast patients with confirmed slash pine sensitization who face a long seasonal burden, Curex now delivers the allergy shot itself at home for $129/month — the serum sterile-compounded to USP <797>, a prescribed epinephrine auto-injector confirmed on hand, and the first dose plus every dose change supervised live over Zoom — removing the extended weekly clinic-visit schedule that the Southeast's warm-season build-up period once required.
What Slash Pine SCIT Actually Costs
Most major insurers cover inhalant SCIT under standard allergy benefits when ordered by a board-certified allergist with documented pine-specific sensitization. Slash pine extract is non-standardized; prior authorization may be required. Verify coverage for CPT 95165 extract preparation before starting. Curex at-home IgE testing identifies specific slash pine sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
Flat monthly subscription — includes consult, prescription, and at-home dosing for sublingual immunotherapy.
See if you qualifyStop guessing about your slash pine allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Slash Pine SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
The visible yellow coating on cars and outdoor surfaces in coastal Southeast cities in March–April is predominantly slash pine (Pinus elliottii) pollen — it is real, abundant, and measurable at counts exceeding 1,000 grains/m³ at NAB Tampa and Jacksonville stations. However, abundant pollen does not equal high allergenicity. Bucholtz et al. (J Allergy Clin Immunol, 1985) found only 3.2% of pollen-sensitive patients tested positive to Pinus in an unselected cohort. Most patients reacting to the March–April Southeast season are sensitized to concurrently blooming live oak, bayberry, or sweet gum — not the pine that coats their car.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.